Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aminohenz is a branded generic parenteral nutrition solution marketed by Suncure Lifescience. It is an intravenous (IV) fluid containing a balanced mixture of essential and non-essential amino acids. The product is designed for patients who are unable to maintain adequate nutritional intake through oral or enteral routes, such as those in critical care, post-operative recovery, or suffering from chronic wasting diseases. By providing the necessary substrates for protein synthesis, Aminohenz helps maintain a positive nitrogen balance, supports tissue repair, and prevents muscle catabolism. It is typically categorized under the company's Criticure division and is available in 100ml and 200ml presentations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Aminohenz.